Rational Decision Making
MBDAAs are tools for effect rational decision making on the health care of patients in a cost-effective manner.
MBDAAs can replace standard-of-care technologies, complement criteria, as well as act as other tests confirmation.
MBDAAs can avoid patients from other uncomfortable screening methods, such as colonoscopy or biopsy.
MBDAAs are cheaper than other procedures and, in some cases, the only option if it is not possible to access the tumor.
As our MBDAAs work at molecular level (both proteic and genetic), types and subtypes of disease can be diagnosed accurately.
MBDAAs can show early detection of illness in healthy people before symptoms develop, increasing recovery chance.
Doctors may use changes in the presence or amount of one or more biomarkers to assess how the illness is responding to treatment.
Monitor for Recurrence
Looking for changes in the amount of a biomarker may help as follow-up care plan to detect a recurrence sooner than other methods.